Curriculum Vitae
Charles M. Beasley, Jr., M.D.

8161 Beech Knoll

Indianapolis, IN 46256-2107

+1.317.506.4800 Mobile

charlesmbeasleyjr(at)msn.com

 

PROFESSIONAL POSITIONS

Beasley Pharmaceutical and Biotechnology Consulting LLC                   May 2015-present

Founder and President

 

Eli Lilly and Company                                                   July 1987-April 2015

Global Patient Safety (GPS)                                          April 2004-April 2015

Distinguished Lilly Scholar                                              Oct. 2004-April 2015                 

Distinguished Lilly Fellow                                              April 2004-Oct. 2004

Neuroscience Business Unit                                         Jan. 2003-April 2004

Distinguished Lilly Fellow

Tadalafil (Cialis®) Product Team                                                                            July 2001-Jan. 2003

Distinguished Lilly Fellow and Medical Director

Olanzapine (Zyprexa®) Product Team                            Jan. 1995-July 2001

Distinguished Lilly Fellow                                               July 1999-July 2001

Medical Advisor                                                             Jan. 1995-July 1999

Neuroscience / Psychopharmacology Division of Clinical Investigation

July 1987-Jan. 1995

Senior Clinical Research Physician                                 March 1992-Jan. 1995

Research Physician                                                      Aug. 1989-March 1992

Associate Clinical Research Physician                             July 1987-Aug. 1989

 

Group Health Associates, Cincinnati, OH                        May1987-June 1987

Physician, Psychiatric Disorders

 

Eating Disorders Center, Cincinnati Medical Center          July 1985-March 1987

Consultant, Medical Support for Bulimia Clinical Trial, Psychiatry Dept.

 

Affective Disorders Center, Cincinnati Medical Center       June 1985-May 1986

Physician, Sub-Investigator for Antidepressant Clinical Trial, Psychiatry Dept.

 

Neuropsychology Laboratory, Yale University School of Medicine    July 1978-Aug. 1979

Associate in Research, Database and Software Designer, Neurology Dept.

 

Dept. Psychology, Yale University                                               June 1977-July 1978

Research Programmer, Software Developer in Machine Learning Artificial

Intelligence Research                                                                                                                            

 

ACADEMIC APPOINTMENTS                                                                                                               

Voluntary Assistant Professor                                                     Jan. 1989-June 1996

Department of Psychiatry, University of Cincinnati

 

POSTGRADUATE TRAINING

University of Cincinnati                                                                       1984-87

Department of Psychiatry; PGY-II-IV, General Psychiatry residency

Yale University                                                                                   1983-84

Department of Psychiatry; PGY-I Flexible intern at the Hospital of St. Raphael

 

EDUCATION

M.D., University of Kentucky College of Medicine                                                                            1983

B.A., Psychology Yale University                                             1977

 

CERTIFICATION AND LICENSURE

National Board of Medical Examiners Diplomate                         1984

American Board of Psychiatry and Neurology Diplomate (Psychiatry) 1988

Medical License: Ohio; Indiana; Maine

 

AWARDS AND HONORS

Sandoz Pharmacology Award 2nd year medical school

Promoted with distinction 2nd and 3rd years medical school

Elected to AOA and AOA president 3rd year medical school

AMA-ERF Rock Sleyster Memorial Scholar 4th year medical school

Cornelia B. Wilbur Psychiatry Departmental Award 4th year medical school

Neurology Departmental Award 4th year medical school

Graduated medical school with high distinction 1983

Laughlin Fellow American College of Psychiatrists, 1987

1st place, Maurice Levine Essay Award Cincinnati Psychiatric Society, 1987

4th Year Resident’s Award Department of Psychiatry, University of Cincinnati, 1987

Resident’s Research Award Department of Psychiatry, University of Cincinnati, 1987

Founder’s Day Resident Award Paper Ohio Psychiatric Association, 1987

 

PROFESSIONAL SOCIETY FELLOWSHIPS

American Psychiatric Association
American College of Psychiatrists
American College of Neuropsychopharmacology
Royal College of Physicians of the United Kingdom

 

PROFESSIONAL SOCIETY MEMBERSHIPS

Indiana Psychiatric Society
American Federation for Clinical Research
American Society of Clinical Psychopharmacology

 

 

 

EDITORIAL BOARD MEMBERSHIPS

Section Editor, Psychopharmacology The Open Pharmacology Journal

Editorial Board Current Psychopharmacology

Editorial Board World Journal of Psychiatry

Editorial Board The Scientific World Journal

Editorial Board ISRN Psychiatry

Editorial Board Journal of Cardiovascular Disorders

 

REVIEWER

Journal of Clinical Psychopharmacology
Archives of General Psychiatry
Psychological Bulletin
Psychological Medicine
Biological Psychiatry
Neuropsychiatric Diseases and Treatment
Progress in Nero-Psychopharmacology & Biological Psychiatry
American Journal of Psychiatry

 

OTHER PROFESSIONAL ACTIVITIES

Reviewer:  Hanson S, Davis M, Altevogt B.  CNS Clinical Trials: Suicidality and Data Collection Workshop Summary. Washington, DC:  Institute of Medicine, 2010.

Co-chairperson History Committee American College of Neuropsychopharmacology 2008-2010

Co-chairperson PMA Education & Research Institute Pharmacology Training Series: Central    Nervous System Pharmacology Washington, D.C. Sep 29-30, 1993

co-chairperson Paper Session 41: Comorbidity in affective disorders American Psychiatric Association Annual Meeting Montreal, Canada May 12, 1988

 

PATENTS ISSUED

5605897       2-Methyl-Thieno-Benzodiazepine (Olanzapine)
5817656       Method for Treating Mental Disorders (Olanzapine)
5817657       Method for Treating Psychoactive Substance Disorders (Olanzapine)
5776928       Method for Treating Dyskinesia (Olanzapine)
6071902       Method for Treating Excessive Aggression (Olanzapine)
6159963       Method for Treating Substance Abuse (Olanzapine)
6274636       Method of Treating Tic Disorder (Olanzapine)
6506746       Method for Treating Cognitive Dysfunction (Olanzapine)

 

 

Charles M. Beasley, Jr.

May 12, 2016